Awareness prog on hepatitis held at Medicover Hospital
On the occasion of World Hepatitis Day, an awareness programme on hepatitis was organised at the local Vageshwari Degree and PG College on Monday.
Speaking on the occasion, Dr. Dilip Reddy said that hepatitis viruses attack the liver, which performs more than 500 vital functions in our body.
Hepatitis is a liver disease. Its main types are M, B, C, D and E viruses and their effects range from low to fatal. They are spread through blood transfusion and sexual contact. Vaccines for hepatitis are available, and everyone should be aware of the vaccines and get them. Hepatitis can be eliminated if precautions are taken, he said.
The programme, held under the aegis of Medicover Hospital Centre Head Gurram Kiran, was attended by Rajeshwari College Chairman BVR Gopal Reddy, Principal Satish Goud, Venkat Reddy, Vice Principal Ramana, Chaitanya, Hospital Marketing Manager Kota Karunakar, Dasari Chandrasekhar, Anil, and students.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
03-08-2025
- Hindustan Times
Health Talk: Taking the road to hepatitis elimination
The International Agency for Research on Cancer (IARC) recently classified hepatitis D as carcinogenic—cancer-causing—to humans, just like hepatitis B and C. Hepatitis D, which only affects individuals infected with hepatitis B, is associated with a two- to six-fold higher risk of liver cancer compared to hepatitis B alone, it added. (AP/ Representative photo) Hepatitis D, which only affects individuals infected with hepatitis B, is associated with a two- to six-fold higher risk of liver cancer compared to hepatitis B alone, it added. Viral hepatitis – types A, B, C, D, and E – are major causes of acute liver infection. Among these, only hepatitis B, C, and D can lead to chronic infections that significantly increase the risk of cirrhosis, liver failure, or liver cancer. Each year, July 28 is observed as World Hepatitis Day, as viral hepatitis continues to remain a serious public health threat and one of the primary causes of liver cancer. Yet most people with hepatitis don't know they're infected, says the World Health Organization (WHO). According to the UN health body, types B, C, and D affect at least 300 million people globally and cause at least 1.3 million deaths each year, mainly from liver cirrhosis and cancer. In a paper published on Monday, The Lancet Commission also mentioned that three in five liver cancer cases happen due to preventable risk factors, including fatty liver, alcohol, and viral hepatitis. It also added that obesity-linked cancer cases are on the rise. The majority of liver cancer cases can be prevented by reducing levels of viral hepatitis, alcohol consumption, and MASLD (metabolic dysfunction-associated steatotic liver disease – previously called non-alcoholic fatty liver disease), it said. Liver cancer is already a major cause of death and disability. Globally, it's the sixth most common cancer and the third leading cause of death from cancer. Interestingly, the Commission estimated in the paper that at least 60% of liver cancers are preventable via control of modifiable risk factors, including hepatitis B virus (HBV), hepatitis C virus (HCV), MASLD, and alcohol. While there are preventive measures and treatment available to combat this public health threat, last year's Global Hepatitis Report underscored some challenges that majorly impact disease management. According to the report, testing and treatment coverage remain critically low: only 13% of people with hepatitis B and 36% with hepatitis C had been diagnosed by 2022. Treatment rates were even lower – 3% for hepatitis B and 20% for hepatitis C – well below the 2025 targets of 60% diagnosed and 50% treated. Integration of hepatitis services remained uneven: 80 countries have incorporated hepatitis services into primary health care, 128 into HIV programmes, and just 27 have integrated hepatitis C services into harm reduction centres. The next challenge, according to the report, will be to scale up the implementation of prevention, testing, and treatment coverage. Achieving WHO's 2030 targets could save 2.8 million lives and prevent 9.8 million new infections. With declining donor support, countries must prioritize domestic investment, integrated services, better data, affordable medicines, and ending stigma, said experts in the report. 'Every 30 seconds, someone dies from a hepatitis-related severe liver disease or liver cancer. Yet we have the tools to stop hepatitis,' WHO director-general Tedros Adhanom Ghebreyesus said in a statement on World Hepatitis Day. He is right. We have the tools at our disposal; all we need is for stakeholders—governments, civil society, community leaders, etc.—to come together, to jointly work towards eliminating hepatitis.
Time of India
01-08-2025
- Time of India
WHO declares Hepatitis D virus as "carcinogenic": What does this mean amidst rising liver diseases
The World Health Organization has declared Hepatitis D as cancer-causing. This announcement coincides with World Hepatitis Day. WHO urges global action against viral hepatitis to reduce liver cancer deaths. Hepatitis affects millions worldwide, causing numerous deaths annually. Early detection and management are crucial. India faces a significant burden of viral hepatitis cases. The World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) have classified the hepatitis D virus (HDV) as carcinogenic to humans. HDV has joined hepatitis B and C on the list of cancer-causing agents. On Monday, during the occasion of World Hepatitis Day, July 28, 2025, WHO urged governments and partners to accelerate efforts to eliminate viral hepatitis as a public health threat and reduce liver cancer deaths. Hepatitis (B, C, and, D) affects over 300 million people globally and claims 1.3 million lives each year, mainly from liver cirrhosis and cancer. "Every 30 seconds, someone dies from a hepatitis-related severe liver disease or liver cancer. Yet we have the tools to stop hepatitis,' Dr Tedros Adhanom Ghebreyesus, WHO Director-General, said in a statement. Viral hepatitis (types A, B, C, D, and E), is the major cause of acute liver infection. Hepatitis B, C, and D can result in chronic infections that increase the risk of liver cirrhosis, liver failure, or liver cancer. Yet most people with hepatitis don't know they're infected. What is Hepatitis D Hepatitis D, also known as delta hepatitis, is a rare but severe liver infection caused by the Hepatitis D virus. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Moose Approaches Girl At Bus Stop In Chittagong - Watch What Happens Happy in Shape Undo It is rare because it can only infect people who are already infected with the hepatitis B virus (HBV). HDV can only occur as a co-infection or superinfection in people who are HBV-positive. Hepatitis D is carcinogenic The International Agency for Research on Cancer (IARC) has recently classified hepatitis D as carcinogenic to humans. Compared to HBV alone, HDV has a two- to six-fold higher risk of liver cancer, making it a serious infection. By classifying HDV as carcinogenic, the health organizations are hoping to raise awareness, improve screening, and expand access to new treatments for hepatitis D across the globe. 'WHO has published guidelines on testing and diagnosis of Hepatitis B and D in 2024, and is actively following the clinical outcomes from innovative treatments for hepatitis D,' Dr Meg Doherty, incoming Director of Science for Health at WHO, said. What is the treatment for HDV? Oral medication can treat Hepatitis C within 2 to 3 months, while effectively controlling hepatitis B with lifelong treatment. The treatment options for HDV, on the other hand, are still developing. Major progress in preventing liver cirrhosis and cancer deaths depends on further steps in managing the global burden such as vaccination, testing, harm reduction, and treatment. In a 2024 report , the WHO had said that India had over 3.5 crore cases of viral hepatitis, including 2.98 crore hepatitis B cases, in 2022, which accounts for 11.6% of the total disease burden globally that year. 7 Ways to check for fatty liver at home Liver diseases are on the rise globally, and HDV being classified as carcinogenic has raised concerns. It adds to the urgency to address this growing crisis, as co-infections exacerbate liver damage and cancer risk. Regular screening and early detection of co-infections, including HDV, will be crucial in reducing the global burden of viral hepatitis
Economic Times
31-07-2025
- Economic Times
They save lives, but who saves them? Surgeons face silent injuries in operation theatres; AIIMS and IIT-Delhi step in
Indian surgeons face health risks during long laparoscopic surgeries. IIT Delhi and AIIMS are collaborating to address this. They are designing new laparoscopic tools. The goal is to reduce strain and prevent long-term injuries. Prototypes for graspers, scissors, and needle holders are under development. Simulations are planned for January. Tired of too many ads? Remove Ads Why are surgeons in pain? What's the solution? Tired of too many ads? Remove Ads Why it matters Surgeons may be saving lives every day, but they're often putting their own health at risk in the process, especially during long laparoscopic surgeries. These operations, which require working with long, rigid tools while watching a screen, force doctors into stressful positions for hours. Shoulders stay hunched, wrists twist, and necks strain, all of which can lead to pain, fatigue, and serious long-term tackle this growing problem, IIT Delhi and AIIMS have teamed up to create a new generation of laparoscopic instruments with better design and ergonomics, reported robotic or open surgery, laparoscopic procedures limit how much a surgeon can move. 'We are working with 300mm-long tools, performing complex surgeries without the feel of touch,' explained Dr Sachit Anand, a paediatric surgeon at AIIMS. 'The stress on our muscles and joints is huge, but it's rarely discussed.'Prof Sabyasachi Paldas from IIT Delhi added that the design of existing tools causes repetitive hand movements and awkward body positions. This often results in musculoskeletal disorders that can affect a surgeon's ability to work in the long term.A joint team of surgeons and designers, including students like Nabeeha Akhtar from IIT Delhi, is using a detailed, multi-stage process to develop better tools. They are working on prototypes for graspers, scissors, and needle holders that aim to reduce stress on the body. The goal is to have working models ready by December, with simulations planned for January.'We're focusing on reducing fatigue and pain by improving posture and movement,' said Dr Gourab Kar from the IIT design department. He added that they're also looking at changes in the operating room itself, like adjusting the table height and monitor position.'In laparoscopy, you work in 2D but aim for 3D outcomes. Every move outside the body needs to be precise inside,' said Dr Anand. 'This puts extra pressure on the surgeon's wrists, fingers, spine and shoulders. It's even harder in Indian hospitals where we see high patient numbers and low awareness about ergonomics.'This initiative comes as India marks World Hepatitis Day with a focus on safer healthcare. It serves as a timely reminder that safety in healthcare should also include the well-being of doctors. After all, a healthy surgeon is essential for healthy from TOI
